No Data
No Data
Toa Construction Industry: Verification Document
Toa: Financial Report - 134th Term (2023/04/01 - 2024/03/31)
Toa Construction Industry: Interim Report
Three points to watch in the morning session: aiming for a rebound in high-tech stocks despite the stalemate.
In the morning of the 19th trading day, the following three points deserve attention: ■ Aiming for a rebound in high-tech stocks despite the stalemate ■ Teijin, downward revision of operating profit to 16 billion yen from 26 billion yen ■ Focus of the morning: Tamura Manufacturing enters railway current sensors and expands into Europe and the United States ■ Despite the stalemate, the Japanese stock market on the 19th is likely to have a strong market development feel after a round of buying. In the US market on the 18th, the NY Dow rose 56 dollars and the Nasdaq rose 5 points.
3 points to pay attention to in the front field ~ High-tech led development in response to NVIDIA's drastic rise ~
I would like to pay attention to the following 3 points in the pre-market transaction on the 29th. ■ High-tech-led developments in response to a significant increase in NVIDIA ■ AZEAS, 24/4 downward revised operating income of 291 million yen ← 536 million yen ■ Featured materials from the front: Asahi Kasei, Swedish Pharma acquisitions, expansion of the kidney disease area ■ High-tech-led developments in response to NVIDIA's drastic rise The Japanese stock market on the 29th seems to be a solid market development even though it continues to be at a stalemate. In the US market on the 28th, the NY Dow depreciated by 216 dollars, NASDAQ
Asahi Kasei, Mitsubishi Heavy, etc. [List of brand materials from newspapers]
*NTT <9432>Cable development that can be installed in road surface grooves without the need for utility poles in optical communication networks (Nikkan Kogyo 1 side) - ○*Toyota's <7203> new engine announced, 4-cylinder 1500cc/2000cc (Nikkan Kogyo 1 side) - ○*SOMPO <8630> new mid-term plan, ROE raised to 15%, and expanded overseas insurance (Nikkan Kogyo 3 sides) - ○*Asahi Kasei <3407> acquires Swedish Pharma and expands kidney disease area (Nikkan Kogyo 3 sides) -○*living in the kidney disease area Tomo Corporation <8053> Entry of offshore wind support ships,
No Data